1. Home
  2. RYN vs CYTK Comparison

RYN vs CYTK Comparison

Compare RYN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$20.46

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$77.07

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
CYTK
Founded
1926
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.6B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
RYN
CYTK
Price
$20.46
$77.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
19
Target Price
$26.00
$89.26
AVG Volume (30 Days)
1.9M
2.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
11.73%
N/A
EPS Growth
26.78
N/A
EPS
3.03
N/A
Revenue
$484,485,000.00
$13,368,000.00
Revenue This Year
$214.97
$7.37
Revenue Next Year
$10.35
$310.19
P/E Ratio
$6.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.49
$29.31
52 Week High
$27.34
$80.20

Technical Indicators

Market Signals
Indicator
RYN
CYTK
Relative Strength Index (RSI) 41.96 69.50
Support Level $19.49 $58.59
Resistance Level $21.68 N/A
Average True Range (ATR) 0.48 3.62
MACD -0.08 1.39
Stochastic Oscillator 11.62 84.90

Price Performance

Historical Comparison
RYN
CYTK

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: